Archives

#VIbsc We are glad to welcome our new speaker LENN

#VIbsc We are glad to welcome our new speaker LENNEKE DE WINTER, Senior Scientist USP, @PolpharmaB for our 15th Bio… https://t.co/2awLO8UIE7

#VIbsc Presenting our new speaker MICHEL MIKHAIL ,

#VIbsc Presenting our new speaker MICHEL MIKHAIL , International Expert in Biosimilars, Global Expert in Regulatory… https://t.co/qRJmMEkciq

#VIbsc @ber_oomen, Executive Director, @esno_web j

#VIbsc @ber_oomen, Executive Director, @esno_web
joins us as a new speaker for our 15th Biosimilars Congregation 2… https://t.co/citoUGmWMk

#VIbsc Announcing our new speaker RENE ANOUR @anou

#VIbsc Announcing our new speaker RENE ANOUR @anournovels, Senior Clinical Expert/Head of National Scientific Advic… https://t.co/av8EQOuC54

Join us at this week’s @EuropeanBiosim1 as @Fros

Join us at this week’s @EuropeanBiosim1 as @Frost_Sullivan’s Deepak Jayakumar shares his insights into factors dict… https://t.co/e6z0aBeBMx

Do we need to give more than Pediatric #Crohns pat

Do we need to give more than Pediatric #Crohns patients Exclusive Enteral Nutrition #EEN to reduce Leaks? Less anti… https://t.co/Ri7Opyjp9W

Adalimumab Biosimilars Insight Report, 2020 by Del

Adalimumab Biosimilars Insight Report, 2020 by DelveInsight https://t.co/O39GOIR56O https://t.co/TaQmymIjhA

@EdwardLoftus2 @P_DeepakIBDMD #crohnsdisease patie

@EdwardLoftus2 @P_DeepakIBDMD #crohnsdisease patient here, not quite sure what to make of this? Is endoscopic remis… https://t.co/YcnEGPOSrB

@realDoc_Strange Have bone marrow cancer after 2 r

@realDoc_Strange Have bone marrow cancer after 2 rounds thyroid cancer 20 yrs apart. Had big vegetable garden, ate… https://t.co/jE9nxrlpH0